JD Supra

DEA Proposes Updates to Rules for Prescribing Controlled Substances That Could Significantly Impact Telemedicine Companies and Their Investors

For elements 7 and 8 above, the NPRM describes how the DEA may adopt one or both proposals. The appointment of a lead for the DEA by President-elect Donald Trump remains pending, leaving uncertainty ...
RAPS

DEA Scheduling Reform Bill Moves Forward in House

The House of Representatives’ Energy and Commerce Committee has voted in favor of new legislation that would reform the way in which the US Drug Enforcement Administration (DEA) schedules new drug ...
Opinion
The Western Journal on MSNOpinion

Four inconvenient truths about Schedule III marijuana

Recently, the Department of Justice and the Drug Enforcement Administration moved marijuana products regulated by state medical marijuana licenses from Schedule I to Schedule III of the Controlled ...
JD Supra

DEA rescheduling of marijuana: Initial steps taken, broader Schedule III review still pending

The United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) recently issued a press release announcing a final ...
WVEC

Medical marijuana reclassified as Schedule III by Trump: What other drugs are on the list?

INDIANAPOLIS — President Donald Trump's acting attorney general has signed an order reclassifying state-licensed medical marijuana as a less-dangerous drug. The move changes medical marijuana from a ...
The Gazette

FDA and DEA propose Schedule 1 ban on kratom-derived compound 7-OH

The U.S. Food and Drug Administration and Drug Enforcement Administration are considering classifying 7-OH, a compound derived from the kratom plant, as a Schedule 1 controlled substance — effectively ...